{"id":"W2014636870","doi":"10.1212/wnl.0b013e3181c34b47","title":"Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease","year":2009,"lang":"en","type":"article","venue":"Neurology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1282,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"U.S. Army Medical Research Acquisition Activity; National Institutes of Health; Supernus Pharmaceuticals; ACADIA Pharmaceuticals; Neuroscience Research Australia; National Institute of Mental Health; Demensförbundet; Pfizer; U.S. Department of Defense; Sanofi; Michael J. Fox Foundation for Parkinson's Research; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; Ipsen; U.S. Department of Veterans Affairs; Lewy Body Dementia Association","keywords":"Montreal Cognitive Assessment; Dementia; Receiver operating characteristic; Medicine; Neuropsychology; Confidence interval; Cognition; Psychology; Psychiatry; Internal medicine; Audiology; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}